
|Articles|October 15, 2006
Study of PE drug shows efficacy over placebo
Minneapolis-For men suffering from the most common sexual dysfunction, premature ejaculation, an investigational drug therapy may offer improved control over ejaculation and sexual satisfaction with a relatively low incidence of side effects.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
ORIC-944 shows promise in combination with ARPIs for mCRPC
2
Jason Hafron, MD, recaps prostate cancer data from ESMO 2025
3
Beyond PSA: Jonathan Henderson, MD, on precision tools for prostate cancer
4
Radioligands and ADT alternatives emerge in prostate cancer treatment
5



















